TAIWAN LIPOSOME
Taiwan Liposome Company (TLC) is a biopharmaceutical company focused on the research, development and commercialization of innovative pharmaceutical products based on its proprietary drug delivery technologies. Our strengths lie in lipid-based formulation and scale-up for parenteral drugs using micelles and nanoparticles to optimize the pharmacokinetics of drugs for better efficacy and lower toxicity, and thus prolong the product lifecycle of branded drugs.
TAIWAN LIPOSOME
Industry:
Biotechnology Health Care Medical
Founded:
1997-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.tlcbio.com
Total Employee:
101+
Status:
Active
Contact:
886 2 2655 7377
Technology used in webpage:
IPhone / Mobile Compatible SPF Domain Not Resolving SSL By Default HSTS LetsEncrypt Global Site Tag US Privacy User Signal Mechanism Microsoft Exchange Online Office 365 Mail
Similar Organizations
CanFite BioPharma
Can-Fite BioPharma is a bio-pharmaceutical company with fully integrated pharmaceutical discovery and clinical development capabilities.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
Kerentech
Fundraising in Life Sciences for Companies developing new drugs, medical devices, healthcare platforms. Scouting.
iTind
iTind is committed to improve the quality of life in the male population by commercializing an office based procedure for BPH.
nkf-pharma
Nanjing King-friend Biochemical Pharmaceutical is focused on research, production, and sales of raw material medicines of heparin sodium.
Octave Life Sciences
Octave Life Sciences is a pharmaceutical firm that is actively involved in the marketing of medicinal products.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Tianyuan Bio-Pharmaceutical
Zhejiang Tianyuan Bio-pharmaceutical Company Limited is engaged in the development and marketing of disease prevention solutions.
Current Employees Featured
Founder
Stock Details
Official Site Inspections
http://www.tlcbio.com Semrush global rank: 8.11 M Semrush visits lastest month: 647
- Host name: 103-129-169-61.static.ip.net.tw
- IP address: 103.129.169.61
- Location: Taiwan
- Latitude: 23.5
- Longitude: 121
- Timezone: Asia/Taipei
More informations about "Taiwan Liposome"
TLC BioSciences | HOME
We are committed to the research and development of best-in-class nanomedicines to fulfill medical unmet needs.See details»
TLC BioSciences | ABOUT
At TLC, we are dedicated to the research, development, and commercialization of novel nanomedicines that maximize the potential of our proprietary lipid-assembled drug delivery …See details»
TLC BioSciences | ABOUT
Founded in 1997 by renowned liposome scientist Dr. Keelung Hong, TLC BioSciences is advancing innovative lipid-based drug delivery technologies.See details»
TLC - The Org
At TLC, we develop novel nanomedicines that maximize the potential of our lipid-based drug delivery technologies. We are currently focused on creating new therapies in the areas of …See details»
Member Profile - TRPMA Official Website
TLC BioSciences is a late clinical-stage specialty pharmaceutical company dedicated to the research, development, and commercialization of novel nanomedicines that maximize the …See details»
TLC BioSciences - LinkedIn
At TLC, we are dedicated to the development of novel nanomedicines that maximize the potential of our proprietary LipAD® lipid-assembled delivery system to enable sustained release and/or targeted deliveries that reduce toxicity and …See details»
TLC BioSciences - LinkedIn
TLC BioSciences | 447 followers on LinkedIn. Delivering Hope for Life | At TLC, we are dedicated to the development of novel nanomedicines that maximize the potential of our proprietary …See details»
Taiwan Liposome Company, Ltd. - AnnualReports.com
Spokesperson Name: Yunlong Tseng Title: Vice President Tel: 886-2-2655-7377 E-mail: [email protected] Deputy Spokesperson Name, Title: Yvonne Shih, Senior DirectorSee details»
TLC BioSciences | ABOUT
With imminent commercial launches in next couple of years and support from a seasoned leadership team, TLC is realizing our founding mission - delivering transformative lipid …See details»
TLC Biosciences - BIO International Convention | BIO
TLC BioSciences is a clinical-stage specialty pharmaceutical company dedicated to the research and development of novel nanomedicines that maximize the potential of its proprietary lipid-assembled drug delivery platform (LipAD®).See details»
TLC Announces Approval of New Drug Application of Liposomal ...
May 25, 2021 SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical …See details»
TLC Announces Approval of New Drug Application of Liposomal ...
May 25, 2021 CONTACT: TLC Contact: Dawn Chi Corporate Communications [email protected]. SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 …See details»
TLC BioSciences - LinkedIn
TLC BioSciences | 575 volgers op LinkedIn. Delivering Hope for Life | At TLC, we are dedicated to the development of novel nanomedicines that maximize the potential of our proprietary …See details»
TLC to Present Preclinical Data on TLC178 at ESMO 2019
Sep 23, 2019 The poster presentation can be accessed under “Publications” in the Pressroom section of TLC’s website at www.tlcbio.com. About TLC178.See details»
TLC BioSciences | Taipei - Facebook
TLC BioSciences, Nangang District. 342 likes. LipAD® technology platforms for sustained release / targeted delivery of known drugsSee details»
TLC BioSciences | CONTACT
Click “STAY” to return to tlcbio.com or “CONTINUE” to proceed. STAY. CONTINUE. Committed to providing you with exceptional service. Contact. We are eager to hear your thoughts and …See details»
Taiwan Liposome - Crunchbase Company Profile & Funding
Taiwan Liposome Company (TLC) is a biopharmaceutical company focused on the research, development and commercialization of innovative pharmaceutical products based on its …See details»
TLC BioSciences | PIPELINE
TLC's pipeline is focused on developing nanomedicines that combine proprietary lipid-assembled drug delivery platforms with approved APIs, emphasizing pain management candidates like …See details»
TLC BioSciences Announces Publication of TLC599 Phase II Results …
Mar 7, 2022 TLC599 reduces pain and improves function for up to 24 weeks, longer than existing intraarticular treatments, and significantly reduces oral medication useSOUTH SAN …See details»
TLC BioSciences | TECHNOLOGY
Click “STAY” to return to tlcbio.com or “CONTINUE” to proceed. STAY. CONTINUE. LipAD® - Proprietary Lipid-Assembled Drug Delivery Platforms. Technology. Overview.See details»